Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04926948
PHASE1

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This phase I trial studies the effect of stereotactic body radiation therapy and immunotherapy in treating patients with mesothelioma. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving stereotactic body radiation therapy and immunotherapy may improve the tumors response to the treatment and decrease side-effects.

Official title: SBRT With Immunotherapy for Mesothelioma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2021-07-12

Completion Date

2026-05-25

Last Updated

2025-10-22

Healthy Volunteers

No

Interventions

OTHER

Immunotherapy

Immunotherapy

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States